Table 1.
Characteristics of HIV+ women by depression status, N=1,352 (April 2004 – March 2005).
Variables | Met criteria for major depressive disorder (CIDI lifetime diagnosis + 12-mo CES-D≥16) | Met criteria for clinically significant depressive symptoms (12-mo CES-D≥16) | Did not meet criteria for depression (CES-D<16 +/or no CIDI lifetime diagnosis) |
---|---|---|---|
n=182 | n=557 | n=795 | |
African American, no. (%) | 111 (61.0) | 298 (53.5) | 397 (54.4) |
Hispanic/Latina, no. (%) | 41(22.5) | 180 (32.3)* | 198 (27.1) |
Caucasian, no. (%) | 21 (11.5) | 61 (11.0)** | 118 (16.2) |
High school graduate, no. (%) | 113 (62.4) | 293 (52.7)*** | 469 (64.2) |
Consistent healthcare provider, no. (%) | 151 (83.0) | 436 (78.3) | 586 (80.3) |
Functional impairment, SF-12 MOS role function scale, 0–100, mean (SD) | 33.3 (28.9)*** | 30.1 (31.0) *** | 13.5 (23.9) |
Age, y, mean (SD) | 42.2 (7.8) | 43.4 (8.6) | 43.4 (8.7) |
Any health insurance, no. (%) | 160 (87.9) | 477 (85.6) | 641 (87.8) |
Out-of-pocket medical care payments, no. (%) | 57 (31.3)* | 132 (23.7) | 183 (25.1) |
On HAART past 6 or 12 months, no. (%) | 117 (64.3) | 360 (64.6) | 501 (68.6) |
Antidepressants for depression, no. (%) | 82 (45.1)*** | 196 (35.2)*** | 115 (15.8) |
Psychotherapy for depression, no (%) | 102 (56.0)*** | 256 (46.0)*** | 164 (22.5) |
Met criteria 1 for adequate tx., no. (%) | 64 (35.2)*** | 150 (26.9)*** | 83 (11.4) |
Met criteria 2 for adequate tx., no. (%) | 70 (38.5)*** | 146 (26.2)*** | 89 (12.2) |
Met criteria 1 or 2 for adequate tx., no. (%) | 84 (46.2)*** | 211 (37.9)*** | 127 (17.4) |
Any depression treatment inclu antidepressants and/or psychotherapy, no. (%) | 105 (57.7)*** | 266 (47.8)*** | 173 (23.7) |
Abbreviations: CIDI - Composite International Diagnostic Interview; SF-12-MOS - Medical Outcomes Study Short Form Health Survey; Criteria 1- four or more outpatient visits with any type of doctor for pharmacotherapy with an antidepressant or mood stabilizer; Criteria 2- eight or more therapy sessions of at least thirty minutes with a mental health professional for psychotherapy; HAART - highly active antiretroviral therapy
p<.05,
p<.01,
p<.001 chi-square/ANOVA for MDD vs. not depressed; CSD vs. not depressed (Source: Women’s Interagency HIV Study 2004–2005)